A new study has indicated that the surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient.
"In most patients, the initial treatment for Stage I and Stage II NSCLC is surgery," said researcher Jayanth Adusumalli, MBBS, of the Creighton University Medical Center in Omaha, Nebraska. "In our study of more than 1,200,000 patients diagnosed with NSCLC in US hospitals between the years 2000 and 2010, we found statistically significant ...
↧